** LeMaitre Vascular's LMAT.O shares down 8.5% to $92.10, hit lowest since Oct 31 early Mon, as medical device co looks to raise capital
** Burlington, Massachusetts-based implants provider offering privately $150 mln convertible bonds (CBs) due Feb 2030
** It plans to use net proceeds, including purchase of additional notes, for general purposes, including potential acquisitions or investments in complementary companies, products, or technologies
** Co had ~$2.3 bln market cap as of Fri, per LSEG
** Despite move on the session, stock up ~63% YTD. Shares hit record intraday high of $109.58 three weeks ago
** Of 10 analysts covering LMAT, 7 rate "strong buy" or "buy", rest "hold" with $100 median PT - LSEG
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380 ))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。